newsfilter
← Latest News
GlobeNewswire·

Lexeo Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference

NEW YORK, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (NASDAQ:LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today announced that